News & Highlights
BIRCWH Scholar Katy Kozhimannil published in PLOS Medicine
Kozhimannil was published for her article titled, "Maternal Clinical Diagnoses and Hospital Variation in the Risk of Cesarean Delivery: Analyses of a National US Hospital Discharge Database".
Jean Wyman, Co-Director of the Powell Center, receives the Nurse Leader in Aging Award
The Powell Center congratulates Jean Wyman! She received the Nurse Leader in Aging Award from the American Academy of Nursing for revolutionary research and leadership on continence and healthy aging.
Alicia Allen Selected as Newest BIRCWH Scholar
Dr. Allen is an Assistant Assistant Professor in the Department of Family Medicine and Community Health. Her research focuses on smoking prevention and cessation treatments.
University of Pennsylvania, Department of Medicine has retained Tyler & Company for an exciting search for a Chief of General Internal Medicine
Penn Medicine is committed to remain a world-leading institution in three equally valued and inter-related missions of patient care, education, and research. The success of these missions requires the integration of the School of Medicine and Health Services and a shared destiny with the University of Pennsylvania. By recruiting and retaining a world-class faculty and staff who strive for excellence, innovation, quality, and professionalism, we will accomplish our missions.
Identifying the Biological Clock that governs Female Fertility
The biological clock that governs female fertility has been identified by researchers. The discovery represents a major contribution to research aimed at finding medical approaches to treating infertility in women.
Genetic Variant protects some Latina Women from Breast Cancer
A genetic variant common in Latina women protects against breast cancer, an international research collaboration has found. The variant, a difference in just one of the three billion "letters" in the human genome known as a single-nucleotide polymorphism (SNP), originates from indigenous Americans and confers significant protection from breast cancer, particularly the more aggressive estrogen receptor-negative forms of the disease, which generally have a worse prognosis.
Personalized Ovarian Cancer Vaccines set for Human Trials
It may not be too long before there is a personalized vaccine to treat patients with ovarian cancer, according to a new study. Researchers from the University of Connecticut say the vaccine stems from a new technique that identifies protein mutations in cancer cells, and the method is already set to enter human trials.